Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | KCNIP2 | Human | 2,4-D | multiple interactions | ISO | Kcnip2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol more ... | CTD | PMID:37567420 | KCNIP2 | Human | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of KCNIP2 mRNA | CTD | PMID:20188158 | KCNIP2 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of KCNIP2 mRNA | CTD | PMID:26251327 | KCNIP2 | Human | 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione | multiple interactions | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of KCNIP2 mRNA] | CTD | PMID:16385079 | KCNIP2 | Human | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of KCNIP2 mRNA | CTD | PMID:27685785 | KCNIP2 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Kcnip2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of KCNIP2 gene | CTD | PMID:31683443 | KCNIP2 | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of KCNIP2 mRNA | CTD | PMID:36041667 | KCNIP2 | Human | 4,4'-sulfonyldiphenol | decreases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of KCNIP2 mRNA | CTD | PMID:30951980 | KCNIP2 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of KCNIP2 mRNA | CTD | PMID:24780913 | KCNIP2 | Human | acrylamide | decreases expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of KCNIP2 mRNA | CTD | PMID:28959563 | KCNIP2 | Human | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of KCNIP2 mRNA | CTD | PMID:32763439 | KCNIP2 | Human | aldehydo-D-glucose | increases methylation | ISO | Kcnip2 (Mus musculus) | 6480464 | Glucose results in increased methylation of KCNIP2 gene and Glucose results in increased methylation of KCNIP2 promoter | CTD | PMID:31525975 and PMID:33448797 | KCNIP2 | Human | aldehydo-D-glucose | decreases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | Glucose results in decreased expression of KCNIP2 mRNA | CTD | PMID:31525975 and PMID:33448797 | KCNIP2 | Human | aldehydo-D-glucose | multiple interactions | ISO | Kcnip2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol more ... | CTD | PMID:33448797 and PMID:37567420 | KCNIP2 | Human | all-trans-retinoic acid | multiple interactions | ISO | Kcnip2 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNIP2 mRNA | CTD | PMID:36189433 | KCNIP2 | Human | alpha-Zearalanol | increases expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Zeranol results in increased expression of KCNIP2 mRNA | CTD | PMID:35163327 | KCNIP2 | Human | ammonium chloride | affects expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of KCNIP2 mRNA | CTD | PMID:16483693 | KCNIP2 | Human | benzo[a]pyrene | multiple interactions | ISO | Kcnip2 (Mus musculus) | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to KCNIP2 promoter] | CTD | PMID:19654925 | KCNIP2 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of KCNIP2 exon and Benzo(a)pyrene results in increased methylation of KCNIP2 promoter | CTD | PMID:27901495 | KCNIP2 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of KCNIP2 intron | CTD | PMID:30157460 | KCNIP2 | Human | bisphenol A | decreases expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of KCNIP2 mRNA | CTD | PMID:25181051 more ... | KCNIP2 | Human | bisphenol A | multiple interactions | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of KCNIP2 mRNA | CTD | PMID:36041667 | KCNIP2 | Human | bisphenol A | increases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of KCNIP2 mRNA | CTD | PMID:31250031 | KCNIP2 | Human | bisphenol F | multiple interactions | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of KCNIP2 mRNA | CTD | PMID:36041667 | KCNIP2 | Human | cantharidin | decreases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | Cantharidin results in decreased expression of KCNIP2 mRNA | CTD | PMID:36907384 | KCNIP2 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to KCNIP2 gene] | CTD | PMID:28238834 | KCNIP2 | Human | chlorpyrifos | increases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of KCNIP2 mRNA | CTD | PMID:37019170 | KCNIP2 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of KCNIP2 mRNA | CTD | PMID:27392435 | KCNIP2 | Human | D-glucose | multiple interactions | ISO | Kcnip2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol more ... | CTD | PMID:33448797 and PMID:37567420 | KCNIP2 | Human | D-glucose | increases methylation | ISO | Kcnip2 (Mus musculus) | 6480464 | Glucose results in increased methylation of KCNIP2 gene and Glucose results in increased methylation of KCNIP2 promoter | CTD | PMID:31525975 and PMID:33448797 | KCNIP2 | Human | D-glucose | decreases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | Glucose results in decreased expression of KCNIP2 mRNA | CTD | PMID:31525975 and PMID:33448797 | KCNIP2 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of KCNIP2 mRNA | CTD | PMID:37042841 | KCNIP2 | Human | dioxygen | multiple interactions | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of KCNIP2 mRNA | CTD | PMID:33729688 | KCNIP2 | Human | diquat | increases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | Diquat results in increased expression of KCNIP2 mRNA | CTD | PMID:36851058 | KCNIP2 | Human | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of KCNIP2 mRNA | CTD | PMID:31059573 | KCNIP2 | Human | flavonoids | increases expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Flavonoids results in increased expression of KCNIP2 mRNA | CTD | PMID:18035473 | KCNIP2 | Human | fructose | multiple interactions | ISO | Kcnip2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol more ... | CTD | PMID:37567420 | KCNIP2 | Human | fucoxanthin | multiple interactions | ISO | Kcnip2 (Mus musculus) | 6480464 | fucoxanthin inhibits the reaction [Glucose results in decreased expression of KCNIP2 mRNA] and fucoxanthin inhibits the reaction [Glucose results in increased methylation of KCNIP2 gene] | CTD | PMID:33448797 | KCNIP2 | Human | glucose | multiple interactions | ISO | Kcnip2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol more ... | CTD | PMID:33448797 and PMID:37567420 | KCNIP2 | Human | glucose | decreases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | Glucose results in decreased expression of KCNIP2 mRNA | CTD | PMID:31525975 and PMID:33448797 | KCNIP2 | Human | glucose | increases methylation | ISO | Kcnip2 (Mus musculus) | 6480464 | Glucose results in increased methylation of KCNIP2 gene and Glucose results in increased methylation of KCNIP2 promoter | CTD | PMID:31525975 and PMID:33448797 | KCNIP2 | Human | hydrogen cyanide | decreases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | Hydrogen Cyanide results in decreased expression of KCNIP2 mRNA | CTD | PMID:33914522 | KCNIP2 | Human | ketamine | increases expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Ketamine results in increased expression of KCNIP2 mRNA | CTD | PMID:20080153 | KCNIP2 | Human | lead diacetate | increases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | lead acetate results in increased expression of KCNIP2 mRNA | CTD | PMID:22609695 | KCNIP2 | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of KCNIP2 mRNA | CTD | PMID:28903495 | KCNIP2 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of KCNIP2 mRNA | CTD | PMID:35811015 | KCNIP2 | Human | methamphetamine | decreases expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Methamphetamine results in decreased expression of KCNIP2 mRNA | CTD | PMID:35863504 | KCNIP2 | Human | methylparaben | increases methylation | EXP | | 6480464 | methylparaben results in increased methylation of KCNIP2 gene | CTD | PMID:34523531 | KCNIP2 | Human | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Kcnip2 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of KCNIP2 mRNA | CTD | PMID:36189433 | KCNIP2 | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of KCNIP2 mRNA | CTD | PMID:24768652 and PMID:25583101 | KCNIP2 | Human | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of KCNIP2 mRNA | CTD | PMID:35430440 | KCNIP2 | Human | paracetamol | increases expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of KCNIP2 mRNA | CTD | PMID:30723492 | KCNIP2 | Human | phenylephrine | multiple interactions | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | MAPK8 protein affects the reaction [Phenylephrine results in decreased expression of KCNIP2 mRNA] | CTD | PMID:16385079 | KCNIP2 | Human | phenylephrine | decreases expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Phenylephrine results in decreased expression of KCNIP2 mRNA more ... | CTD | PMID:16385079 more ... | KCNIP2 | Human | phorbol 13-acetate 12-myristate | decreases expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of KCNIP2 mRNA | CTD | PMID:16385079 | KCNIP2 | Human | phorbol 13-acetate 12-myristate | multiple interactions | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of KCNIP2 mRNA] | CTD | PMID:16385079 | KCNIP2 | Human | potassium cyanide | increases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | Potassium Cyanide results in increased expression of KCNIP2 mRNA | CTD | PMID:33914522 | KCNIP2 | Human | potassium dichromate | decreases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of KCNIP2 mRNA | CTD | PMID:23608068 | KCNIP2 | Human | prothioconazole | decreases expression | EXP | | 6480464 | prothioconazole results in decreased expression of KCNIP2 mRNA | CTD | PMID:35048155 | KCNIP2 | Human | raloxifene | multiple interactions | EXP | | 6480464 | [KCNIP2 protein co-treated with Raloxifene Hydrochloride] results in decreased activity of KCND3 protein | CTD | PMID:25231973 | KCNIP2 | Human | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of KCNIP2 mRNA | CTD | PMID:35811015 | KCNIP2 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of KCNIP2 mRNA | CTD | PMID:35811015 | KCNIP2 | Human | Soman | decreases expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Soman results in decreased expression of KCNIP2 mRNA | CTD | PMID:19281266 | KCNIP2 | Human | sulforaphane | increases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | sulforaphane results in increased expression of KCNIP2 mRNA | CTD | PMID:30529165 | KCNIP2 | Human | titanium dioxide | decreases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of KCNIP2 mRNA | CTD | PMID:35295148 | KCNIP2 | Human | titanium dioxide | increases methylation | ISO | Kcnip2 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of KCNIP2 promoter | CTD | PMID:35295148 | KCNIP2 | Human | trichloroethene | increases methylation | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased methylation of KCNIP2 gene | CTD | PMID:27618143 | KCNIP2 | Human | trichloroethene | decreases expression | ISO | Kcnip2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of KCNIP2 mRNA | CTD | PMID:33387578 | KCNIP2 | Human | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of KCNIP2 mRNA | CTD | PMID:30510588 | KCNIP2 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of KCNIP2 mRNA | CTD | PMID:37042841 | KCNIP2 | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of KCNIP2 mRNA | CTD | PMID:28818685 | KCNIP2 | Human | vancomycin | increases expression | ISO | Kcnip2 (Mus musculus) | 6480464 | Vancomycin results in increased expression of KCNIP2 mRNA | CTD | PMID:18930951 | |